PGC-1α与线粒体O生成调控在心血管疾病中的作用

被引：18

作者：

郭茜 ^{[1
,2
]}

郭家彬 ^{[1
]}

李梨 ^{[2
]}

彭双清 ^{[1
]}

机构：

[1] 军事医学科学院疾病预防控制所毒理学评价研究中心

[2] 重庆医科大学生物化学和分子生物学教研室

来源：

中国药理学通报 | 2013年 / 01期

关键词：

线粒体生成; PGC-1α; 能量代谢; 转录调控; 信号通路; 心血管疾病;

D O I：

暂无

中图分类号：

R96 [药理学];

学科分类号：

100602 ; 100706 ;

摘要：

线粒体是一类高度活跃的细胞器,在细胞能量代谢等生命活动中具有重要的作用。线粒体生成,即线粒体的增殖以及线粒体系统合成和个体合成的过程。近年来研究提示,线粒体生成与线粒体的功能调节密切相关,而过氧化物酶体增殖物激活受体γ辅激活因子-1α(peroxisome proliferator-ac-tivated receptor gamma co-activator,PGC-1α)可能是线粒体生成的关键调控因子。特别是在心血管系统中,PGC-1α信号途径调控的线粒体生成可能是维持和修复心肌细胞和血管内皮细胞等心血管系统细胞线粒体功能的主要机制之一,在心力衰竭、心肌肥大、糖尿病心血管并发症等心血管疾病的发生与发展过程中具有重要作用。PGC-1α作为心血管疾病疾病预防和治疗的潜在靶标,将有可能为心血管疾病的防治提供新的策略。

引用

页码：1 / 5

页数：5

共 14 条

[1] PGC-1 Coactivators in Cardiac Development and Disease [J].

Rowe, Glenn C. ;

Jiang, Aihua ;

Arany, Zolt .

CIRCULATION RESEARCH, 2010, 107 (07) :825-838

[2] A conserved role for phosphatidylinositol 3-kinase but not akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy [J].

O'Neill, Brian T. ;

Kim, Jaetaek ;

Wende, Adam R. ;

Theobald, Heather A. ;

Tuinei, Joseph ;

Buchanan, Jonathan ;

Guo, Aili ;

Zaha, Vlad G. ;

Davis, Don K. ;

Schell, John C. ;

Boudina, Sihem ;

Wayment, Benjamin ;

Litwin, Sheldon E. ;

Shioi, Tetsuo ;

Izumo, Seigo ;

Birnbaum, Morris J. ;

Abel, E. Dale .

CELL METABOLISM, 2007, 6 (04) :294-306

[3] ERRγ directs and maintains the transition to oxidative metabolism in the postnatal heart [J].

Alaynick, William A. ;

Kondo, Richard P. ;

Xie, Wen ;

He, Weimin ;

Dufour, Catherine R. ;

Downes, Michael ;

Jonker, Johan W. ;

Giles, Wayne ;

Naviaux, Robert K. ;

Giguere, Vincent ;

Evans, Ronald M. .

CELL METABOLISM, 2007, 6 (01) :13-24

[4] Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis [J].

Reznick, Richard M. ;

Zong, Haihong ;

Li, Ji ;

Morino, Katsutaro ;

Moore, Irene K. ;

Yu, Hannah J. ;

Liu, Zhen-Xiang ;

Dong, Jianying ;

Mustard, Kirsty J. ;

Hawley, Simon A. ;

Befroy, Douglas ;

Pypaert, Marc ;

Hardie, D. Grahame ;

Young, Lawrence H. ;

Shulman, Gerald I. .

CELL METABOLISM, 2007, 5 (02) :151-156

[5] Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies [J].

Sebastiani, Mariangela ;

Giordano, Carla ;

Nediani, Chiara. ;

Travaglini, Claudia ;

Borchi, Elisabetta ;

Zani, Massimo ;

Feccia, Mariano ;

Mancini, Massimiliano ;

Petrozza, Vincenzo ;

Cossarizza, Andrea ;

Gallo, Pietro ;

Taylor, Robert W. ;

d'Amati, Giulia .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (14) :1362-1369

[6]

Mitochondrial and energetic cardiac phenotype in hypothyroid rat. Relevance to heart failure[J] . Yoni Athéa,Anne Garnier,Dominique Fortin,Lahoucine Bahi,Vladimir Veksler,Renée Ventura-Clapier.Pflügers Archiv - European Journal of Physiology . 2007 (3)

[7] Sirt1 regulates aging and resistance to oxidative stress in the heart [J].

Alcendor, Ralph R. ;

Gao, Shumin ;

Zhai, Peiyong ;

Zablocki, Daniela ;

Holle, Eric ;

Yu, Xianzhong ;

Tian, Bin ;

Wagner, Thomas ;

Vatner, Stephen F. ;

Sadoshima, Junichi .

CIRCULATION RESEARCH, 2007, 100 (10) :1512-1521

[8]

Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome?[J] . Enzo Nisoli,Emilio Clementi,Michele O. Carruba,Salvador Moncada.Circulation Research . 2007 (6)

[9] Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α [J].